Intraductal papillary neoplasm of the bile ducts: The clinical features and surgical outcome of 25 cases

Journal of Surgical Oncology

Volumn 97, Issue 6, 2008, Pages 508-512

  Kwang, Yeol Paik ^a   Jin, Seok Heo ^b,c   Seong, Ho Choi ^b   Dong, Wook Choi ^b  

^a Hanil General Corporation   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Clinical features; Intraductal papillary neoplasm of the bile ducts (IPN B); Surgical outcome

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BILE DUCT DILATATION; BILE DUCT TUMOR; CANCER SURGERY; CANCER SURVIVAL; CHOLANGIOGRAPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY BILE DUCT CANCER; LIVER RESECTION; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 43049093728     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20994     Document Type: Article

References (22)

1. 1 Isaji S, Kawarada Y, Taoka H, et al.: Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999 ; 6: 108–116.
2. 2 Suh KS, Roh HR, Koh YT, et al.: Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 2000 ; 31: 12–17.
3. 3 Colombari R, Tsui WM: Biliary tumors of the liver. Semin Liver Dis 1995 ; 15: 402–413.
4. 4 Kim YS, Myung SJ, Kim SY, et al.: Biliary papillomatosis: Clinical, cholangiographic and cholangioscopic findings. Endoscopy 1998 ; 30: 763–767.
5. 5 Nakanuma Y, Sripa B, Vantanasapt V, et al.: Intrahepatic cholangiocarcinoma. In: Hamilton SR, Aaltonen LA, editors. World health organization classification of tumours pathology and genetics of tumours of the digestive system. Lyon: IARC Press ; 2000. pp 173–180.
6. 6 Lee SS, Kim MH, Lee SK, et al.: Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer 2004 ; 100: 783–793.
7. 7 Chen MF, Jan YY, Chen TC: Clinical studies of mucin‐producing cholangiocellular carcinoma: A study of 22 histopathology‐proven cases. Ann Surg 1998 ; 227: 63–69.
8. 8 Zen Y, Fujii T, Itatsu K, et al.: Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology 2006 ; 44: 1333–1343.
9. 9 Zen Y, Sasaki M, Fujii T, et al.: Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct—an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 2006 ; 44: 350–358.
10. 10 Shibahara H, Tamada S, Goto M, et al.: Pathologic features of mucin‐producing bile duct tumors: Two histopathologic categories as counterparts of pancreatic intraductal papillary‐mucinous neoplasms. Am J Surg Pathol 2004 ; 28: 327–338.
11. 11 Chen TC, Nakanuma Y, Zen Y, et al.: Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 2001 ; 34: 651–658.
12. 12 Nakanuma Y, Sasaki M, Ishikawa A, et al.: Biliary papillary neoplasm of the liver. Histol Histopathol 2002 ; 17: 851–861.
13. 13 Jarnagin WR, Bowne W, Klimstra DS, et al.: Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 2005 ; 241: 703–712 ; discussion 12–14.
14. 14 Yeh CN, Jan YY, Yeh TS, et al.: Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol 2004 ; 11: 606–611.
15. 15 Kang YK, Kim WH, Lee HW, et al.: Mutation of p53 and K‐ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma. Lab Invest 1999 ; 79: 477–483.
16. 16 Jo Chae K, Rha SY, Oh BK, et al.: Expression of matrix metalloproteinase‐2 and ‐9 and tissue inhibitor of metalloproteinase‐1 and ‐2 in intraductal and nonintraductal growth type of cholangiocarcinoma. Am J Gastroenterol 2004 ; 99: 68–75.
17. 17 Sugimachi K, Taguchi K, Aishima S, et al.: Altered expression of beta‐catenin without genetic mutation in intrahepatic cholangiocarcinoma. Mod Pathol 2001 ; 14: 900–905.
18. 18 Yeh TS, Tseng JH, Chen TC, et al.: Characterization of intrahepatic cholangiocarcinoma of the intraductal growth‐type and its precursor lesions. Hepatology 2005 ; 42: 657–664.
19. 19 Yeh TS, Tseng JH, Chiu CT, et al.: Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg 2006 ; 244: 248–253.
20. 20 Aoki S, Okayama Y, Kitajima Y, et al.: Intrahepatic biliary papilloma morphologically similar to biliary cystadenoma. J Gastroenterol Hepatol 2005 ; 20: 321–324.
21. 21 Zen Y, Fujii T, Itatsu K, et al.: Biliary cystic tumors with bile duct communication: A cystic variant of intraductal papillary neoplasm of the bile duct. Mod Pathol 2006 ; 19: 1243–1254.
22. 22 Yeh TS, Ho YP, Chiu CT, et al.: Aberrant expression of cdx2 homeobox gene in intraductal papillary‐mucinous neoplasm of the pancreas but not in pancreatic ductal adenocarcinoma. Pancreas 2005 ; 30: 233–238.